Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,Leiomyoma of uterus,ACAN,Aggrecan core protein,14863,422,0.44 [0.33-0.60],1.0515992156177648e-07
Chapter II Neoplasms,Leiomyoma of uterus,ACP5,Tartrate-resistant acid phosphatase type 5,15049,430,0.74 [0.57-0.96],0.0210671936475816
Chapter II Neoplasms,Leiomyoma of uterus,ACTA2,"Actin, aortic smooth muscle",14726,419,1.34 [1.14-1.56],0.0003171271379764
Chapter II Neoplasms,Leiomyoma of uterus,ACVRL1,Serine/threonine-protein kinase receptor R3,14863,416,0.62 [0.42-0.92],0.0165848674991399
Chapter II Neoplasms,Leiomyoma of uterus,ACY1,Aminoacylase-1,14989,424,0.83 [0.72-0.96],0.0129363044219876
Chapter II Neoplasms,Leiomyoma of uterus,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,12603,340,0.74 [0.62-0.90],0.0019279114445756
Chapter II Neoplasms,Leiomyoma of uterus,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,12645,344,1.30 [1.13-1.50],0.0002233665999575
Chapter II Neoplasms,Leiomyoma of uterus,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,15104,427,0.73 [0.54-0.99],0.0399939534704735
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,14726,419,1.41 [1.17-1.70],0.0003315739443125
Chapter II Neoplasms,Leiomyoma of uterus,ADAMTSL5,ADAMTS-like protein 5,13013,361,1.29 [1.01-1.65],0.0449976316214252
Chapter II Neoplasms,Leiomyoma of uterus,ADGRE1,Adhesion G protein-coupled receptor E1,12947,357,1.24 [1.04-1.47],0.0160117187510636
Chapter II Neoplasms,Leiomyoma of uterus,ADGRG1,Adhesion G-protein coupled receptor G1,14932,422,1.30 [1.11-1.52],0.0009950616317256
Chapter II Neoplasms,Leiomyoma of uterus,ADGRG2,Adhesion G-protein coupled receptor G2,14989,424,0.49 [0.36-0.67],6.738634193957169e-06
Chapter II Neoplasms,Leiomyoma of uterus,ADH1B,All-trans-retinol dehydrogenase,12715,355,0.83 [0.72-0.95],0.0093344043620745
Chapter II Neoplasms,Leiomyoma of uterus,AFM,Afamin,13027,358,0.53 [0.31-0.91],0.0204677859716711
Chapter II Neoplasms,Leiomyoma of uterus,AGBL2,Cytosolic carboxypeptidase 2,12613,341,0.90 [0.81-0.99],0.0369200868520167
Chapter II Neoplasms,Leiomyoma of uterus,AGER,Advanced glycosylation end product-specific receptor,14965,417,0.77 [0.62-0.95],0.0169309775746311
Chapter II Neoplasms,Leiomyoma of uterus,AGR2,Anterior gradient protein 2 homolog,14489,406,0.92 [0.84-1.00],0.0464875389177885
Chapter II Neoplasms,Leiomyoma of uterus,AGT,Angiotensinogen,13019,364,0.62 [0.39-0.98],0.0421813652747563
Chapter II Neoplasms,Leiomyoma of uterus,AGXT,Serine--pyruvate aminotransferase,14989,424,0.88 [0.78-0.98],0.0255312215103836
Chapter II Neoplasms,Leiomyoma of uterus,AHNAK,Neuroblast differentiation-associated protein AHNAK,12652,351,0.50 [0.36-0.69],3.861112972547711e-05
Chapter II Neoplasms,Leiomyoma of uterus,AHSP,Alpha-hemoglobin-stabilizing protein,14963,426,0.87 [0.79-0.95],0.0023257873541019
Chapter II Neoplasms,Leiomyoma of uterus,AK1,Adenylate kinase isoenzyme 1,14989,424,0.83 [0.73-0.95],0.0062978727799648
Chapter II Neoplasms,Leiomyoma of uterus,AKAP12,A-kinase anchor protein 12,12715,355,0.54 [0.32-0.90],0.0180615331196294
Chapter II Neoplasms,Leiomyoma of uterus,ALCAM,CD166 antigen,15181,433,0.47 [0.30-0.74],0.0009895864688277
Chapter II Neoplasms,Leiomyoma of uterus,ALDH1A1,Retinal dehydrogenase 1,14985,426,0.75 [0.63-0.89],0.0007681727247747
Chapter II Neoplasms,Leiomyoma of uterus,ALDH2,"Aldehyde dehydrogenase, mitochondrial",12940,359,0.78 [0.61-1.00],0.0492774590702535
Chapter II Neoplasms,Leiomyoma of uterus,AMBP,Protein AMBP,15106,428,0.64 [0.41-0.99],0.0429008569388079
Chapter II Neoplasms,Leiomyoma of uterus,AMIGO2,Amphoterin-induced protein 2,14932,422,1.60 [1.09-2.34],0.0156187421192133
Chapter II Neoplasms,Leiomyoma of uterus,AMN,Protein amnionless,14692,416,0.80 [0.66-0.96],0.0180123710505933
Chapter II Neoplasms,Leiomyoma of uterus,ANGPT2,Angiopoietin-2,15123,428,0.81 [0.65-1.00],0.0477976912251753
Chapter II Neoplasms,Leiomyoma of uterus,ANGPTL3,Angiopoietin-related protein 3,14978,430,0.69 [0.55-0.86],0.0011711656075568
Chapter II Neoplasms,Leiomyoma of uterus,ANKRD54,Ankyrin repeat domain-containing protein 54,14633,414,0.80 [0.68-0.95],0.0094096983415313
Chapter II Neoplasms,Leiomyoma of uterus,ANPEP,Aminopeptidase N,14990,430,0.62 [0.46-0.85],0.0028795468078962
Chapter II Neoplasms,Leiomyoma of uterus,APLP1,Amyloid-like protein 1,14989,424,0.78 [0.66-0.92],0.0030789551247092
Chapter II Neoplasms,Leiomyoma of uterus,APOA1,Apolipoprotein A-I,13027,358,0.64 [0.43-0.96],0.0310367772318667
Chapter II Neoplasms,Leiomyoma of uterus,APOA4,Apolipoprotein A-IV,13027,358,0.62 [0.45-0.84],0.0019731407190346
Chapter II Neoplasms,Leiomyoma of uterus,AREG,Amphiregulin,14932,422,1.38 [1.21-1.58],2.421703598132178e-06
Chapter II Neoplasms,Leiomyoma of uterus,ARG1,Arginase-1,14915,424,0.80 [0.69-0.94],0.0048796233534373
Chapter II Neoplasms,Leiomyoma of uterus,ASAH1,Acid ceramidase,12877,354,0.79 [0.63-0.99],0.0392476255728097
Chapter II Neoplasms,Leiomyoma of uterus,AXL,Tyrosine-protein kinase receptor UFO,15023,432,0.64 [0.47-0.88],0.0052289035634995
Chapter II Neoplasms,Leiomyoma of uterus,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",12652,351,0.75 [0.57-0.98],0.0348590714855529
Chapter II Neoplasms,Leiomyoma of uterus,B4GAT1,"Beta-1,4-glucuronyltransferase 1",14985,426,0.65 [0.46-0.93],0.0176416292282263
Chapter II Neoplasms,Leiomyoma of uterus,BCAN,Brevican core protein,14888,417,1.68 [1.29-2.18],0.0001024021798255
Chapter II Neoplasms,Leiomyoma of uterus,BCHE,Cholinesterase,12769,353,0.60 [0.43-0.85],0.0043268605462258
Chapter II Neoplasms,Leiomyoma of uterus,BGLAP,Osteocalcin,12985,359,0.83 [0.75-0.92],0.000594319592643
Chapter II Neoplasms,Leiomyoma of uterus,BID,BH3-interacting domain death agonist,14972,425,0.87 [0.77-0.99],0.035360419701598
Chapter II Neoplasms,Leiomyoma of uterus,BLVRB,Flavin reductase,14985,426,0.88 [0.77-1.00],0.044907901062947
Chapter II Neoplasms,Leiomyoma of uterus,BMP4,Bone morphogenetic protein 4,14863,416,0.82 [0.67-0.99],0.0365813708830367
Chapter II Neoplasms,Leiomyoma of uterus,BMP6,Bone morphogenetic protein 6,14698,419,1.49 [1.21-1.84],0.0001518754783895
Chapter II Neoplasms,Leiomyoma of uterus,BOC,Brother of CDO,14726,419,1.98 [1.39-2.83],0.0001505221212451
Chapter II Neoplasms,Leiomyoma of uterus,BPIFB1,BPI fold-containing family B member 1,14976,427,1.15 [1.01-1.30],0.0410096269792152
Chapter II Neoplasms,Leiomyoma of uterus,BSG,Basigin,15128,428,0.58 [0.39-0.89],0.0116482867800918
Chapter II Neoplasms,Leiomyoma of uterus,BST2,Bone marrow stromal antigen 2,15124,428,0.83 [0.70-0.99],0.0348423102048904
Chapter II Neoplasms,Leiomyoma of uterus,C1QA,Complement C1q subcomponent subunit A,15076,422,2.63 [1.86-3.72],4.9384618010927386e-08
Chapter II Neoplasms,Leiomyoma of uterus,C2,Complement C2,15001,431,0.74 [0.57-0.96],0.0221370816034905
Chapter II Neoplasms,Leiomyoma of uterus,CA1,Carbonic anhydrase 1,14627,423,0.80 [0.70-0.91],0.0011346980151169
Chapter II Neoplasms,Leiomyoma of uterus,CA11,Carbonic anhydrase-related protein 11,14633,414,1.28 [1.04-1.58],0.0215026093305324
Chapter II Neoplasms,Leiomyoma of uterus,CA12,Carbonic anhydrase 12,14932,422,1.76 [1.45-2.14],8.128247094047292e-09
Chapter II Neoplasms,Leiomyoma of uterus,CA2,Carbonic anhydrase 2,14940,423,0.85 [0.76-0.96],0.0107542901606915
Chapter II Neoplasms,Leiomyoma of uterus,CA3,Carbonic anhydrase 3,15154,433,0.75 [0.66-0.87],7.230775704355307e-05
Chapter II Neoplasms,Leiomyoma of uterus,CA4,Carbonic anhydrase 4,15181,433,0.51 [0.36-0.73],0.000210775092134
Chapter II Neoplasms,Leiomyoma of uterus,CA8,Carbonic anhydrase-related protein,12645,344,0.56 [0.34-0.92],0.0210864932970036
Chapter II Neoplasms,Leiomyoma of uterus,CA9,Carbonic anhydrase 9,15123,428,1.25 [1.04-1.50],0.0200421095949401
Chapter II Neoplasms,Leiomyoma of uterus,CAPG,Macrophage-capping protein,14890,421,0.86 [0.74-0.99],0.0423219898485545
Chapter II Neoplasms,Leiomyoma of uterus,CAT,Catalase,12807,356,0.71 [0.59-0.86],0.0005615550855223
Chapter II Neoplasms,Leiomyoma of uterus,CCL15,C-C motif chemokine 15,15181,433,0.78 [0.64-0.95],0.0124699587900868
Chapter II Neoplasms,Leiomyoma of uterus,CCL18,C-C motif chemokine 18,14761,429,0.86 [0.76-0.98],0.0196407983956853
Chapter II Neoplasms,Leiomyoma of uterus,CCL20,C-C motif chemokine 20,15157,428,0.89 [0.79-0.99],0.0284227266534639
Chapter II Neoplasms,Leiomyoma of uterus,CCL25,C-C motif chemokine 25,15157,428,0.81 [0.69-0.96],0.014960103911851
Chapter II Neoplasms,Leiomyoma of uterus,CCL28,C-C motif chemokine 28,14931,425,1.20 [1.05-1.37],0.006846549173722
Chapter II Neoplasms,Leiomyoma of uterus,CCN4,CCN family member 4,15123,428,1.79 [1.49-2.14],2.96638868237953e-10
Chapter II Neoplasms,Leiomyoma of uterus,CD101,Immunoglobulin superfamily member 2,12947,357,0.74 [0.59-0.93],0.010041547228276
Chapter II Neoplasms,Leiomyoma of uterus,CD14,Monocyte differentiation antigen CD14,14633,420,0.73 [0.59-0.89],0.0024652516104726
Chapter II Neoplasms,Leiomyoma of uterus,CD276,CD276 antigen,14993,419,1.35 [1.06-1.72],0.0151498780405385
Chapter II Neoplasms,Leiomyoma of uterus,CD300LG,CMRF35-like molecule 9,14985,426,0.62 [0.49-0.78],4.564019425060077e-05
Chapter II Neoplasms,Leiomyoma of uterus,CD34,Hematopoietic progenitor cell antigen CD34,15066,427,0.52 [0.37-0.74],0.0003199185772415
Chapter II Neoplasms,Leiomyoma of uterus,CD36,Platelet glycoprotein 4,12645,344,0.77 [0.62-0.97],0.0252272219416697
Chapter II Neoplasms,Leiomyoma of uterus,CD46,Membrane cofactor protein,14869,428,0.68 [0.50-0.93],0.0158908312096835
Chapter II Neoplasms,Leiomyoma of uterus,CD55,Complement decay-accelerating factor,14439,418,0.63 [0.44-0.90],0.0115674722911291
Chapter II Neoplasms,Leiomyoma of uterus,CD59,CD59 glycoprotein,14409,410,0.43 [0.27-0.68],0.0003368239119014
Chapter II Neoplasms,Leiomyoma of uterus,CD79B,B-cell antigen receptor complex-associated protein beta chain,15157,428,0.80 [0.65-0.98],0.0348668621913392
Chapter II Neoplasms,Leiomyoma of uterus,CD8A,T-cell surface glycoprotein CD8 alpha chain,15124,428,0.83 [0.70-1.00],0.0453973660135426
Chapter II Neoplasms,Leiomyoma of uterus,CD93,Complement component C1q receptor,14413,417,0.59 [0.45-0.79],0.0004018511667322
Chapter II Neoplasms,Leiomyoma of uterus,CD99L2,CD99 antigen-like protein 2,14985,426,0.59 [0.41-0.85],0.004238429869909
Chapter II Neoplasms,Leiomyoma of uterus,CDC123,Cell division cycle protein 123 homolog,12547,340,0.82 [0.68-0.98],0.0335123651708574
Chapter II Neoplasms,Leiomyoma of uterus,CDC25A,M-phase inducer phosphatase 1,12547,340,0.73 [0.56-0.97],0.0310612013863122
Chapter II Neoplasms,Leiomyoma of uterus,CDH1,Cadherin-1,14447,410,0.62 [0.48-0.79],0.0001741437243625
Chapter II Neoplasms,Leiomyoma of uterus,CDH15,Cadherin-15,15095,428,0.62 [0.49-0.78],4.7545987645983314e-05
Chapter II Neoplasms,Leiomyoma of uterus,CDH17,Cadherin-17,14989,424,0.85 [0.75-0.97],0.0159591304408412
Chapter II Neoplasms,Leiomyoma of uterus,CDH2,Cadherin-2,14989,424,0.73 [0.58-0.93],0.009781506649293
Chapter II Neoplasms,Leiomyoma of uterus,CDH3,Cadherin-3,15124,428,3.48 [2.92-4.16],3.7697554526789e-43
Chapter II Neoplasms,Leiomyoma of uterus,CDH5,Cadherin-5,15181,433,0.58 [0.44-0.77],0.0001612189010147
Chapter II Neoplasms,Leiomyoma of uterus,CDHR2,Cadherin-related family member 2,14932,422,0.78 [0.70-0.88],1.94659426098314e-05
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,12947,357,0.83 [0.74-0.94],0.0025017764246891
Chapter II Neoplasms,Leiomyoma of uterus,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,14972,425,1.12 [1.02-1.24],0.0188186736254468
Chapter II Neoplasms,Leiomyoma of uterus,CENPJ,Centromere protein J,12748,354,0.79 [0.67-0.92],0.0034775940980627
Chapter II Neoplasms,Leiomyoma of uterus,CEP152,Centrosomal protein of 152 kDa,12547,340,0.75 [0.57-0.98],0.0349943088816965
Chapter II Neoplasms,Leiomyoma of uterus,CES1,Liver carboxylesterase 1,15015,425,0.89 [0.79-0.99],0.0406262106578438
Chapter II Neoplasms,Leiomyoma of uterus,CFH,Complement factor H,12270,340,0.57 [0.38-0.88],0.0106978761047077
Chapter II Neoplasms,Leiomyoma of uterus,CFHR5,Complement factor H-related protein 5,12857,355,0.79 [0.63-0.99],0.0426495570162071
Chapter II Neoplasms,Leiomyoma of uterus,CFI,Complement factor I,13027,358,0.44 [0.27-0.71],0.0008294958228433
Chapter II Neoplasms,Leiomyoma of uterus,CFP,Properdin,13027,358,0.40 [0.25-0.66],0.0002846682626954
Chapter II Neoplasms,Leiomyoma of uterus,CGA,Glycoprotein hormones alpha chain,14985,426,0.81 [0.75-0.88],1.80245076521972e-06
Chapter II Neoplasms,Leiomyoma of uterus,CHAD,Chondroadherin,12715,355,0.70 [0.58-0.85],0.0002994798249305
Chapter II Neoplasms,Leiomyoma of uterus,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",12968,358,0.71 [0.54-0.94],0.0158616348087747
Chapter II Neoplasms,Leiomyoma of uterus,CHGB,Secretogranin-1,15063,426,0.73 [0.58-0.91],0.0046786051853373
Chapter II Neoplasms,Leiomyoma of uterus,CHL1,Neural cell adhesion molecule L1-like protein,15000,431,0.72 [0.55-0.94],0.0142367888633287
Chapter II Neoplasms,Leiomyoma of uterus,CHRDL1,Chordin-like protein 1,15043,425,1.47 [1.11-1.95],0.0072629137046343
Chapter II Neoplasms,Leiomyoma of uterus,CHRDL2,Chordin-like protein 2,14989,424,3.06 [2.73-3.43],5.8257023214842265e-83
Chapter II Neoplasms,Leiomyoma of uterus,CKAP4,Cytoskeleton-associated protein 4,15072,428,1.53 [1.11-2.09],0.0085260723442801
Chapter II Neoplasms,Leiomyoma of uterus,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",14932,424,0.85 [0.76-0.94],0.002477075573336
Chapter II Neoplasms,Leiomyoma of uterus,CLEC14A,C-type lectin domain family 14 member A,14985,426,0.63 [0.47-0.84],0.0013801826171532
Chapter II Neoplasms,Leiomyoma of uterus,CLEC3B,Tetranectin,12722,350,0.56 [0.34-0.91],0.0180883980661197
Chapter II Neoplasms,Leiomyoma of uterus,CLEC4G,C-type lectin domain family 4 member G,14972,425,0.76 [0.59-0.98],0.0329681525952736
Chapter II Neoplasms,Leiomyoma of uterus,CLGN,Calmegin,12629,354,0.70 [0.54-0.89],0.0044370445782843
Chapter II Neoplasms,Leiomyoma of uterus,CNGB3,Cyclic nucleotide-gated cation channel beta-3,12613,341,0.78 [0.62-0.98],0.0314010429476455
Chapter II Neoplasms,Leiomyoma of uterus,COCH,Cochlin,13013,361,0.77 [0.62-0.96],0.0174495328457462
Chapter II Neoplasms,Leiomyoma of uterus,COL3A1,Collagen alpha-1(III) chain,12985,359,1.63 [1.08-2.45],0.020149939318356
Chapter II Neoplasms,Leiomyoma of uterus,COL4A1,Collagen alpha-1(IV) chain,14989,424,1.64 [1.34-2.02],2.1705489011956024e-06
Chapter II Neoplasms,Leiomyoma of uterus,COL5A1,Collagen alpha-1(V) chain,12715,355,1.52 [1.20-1.93],0.0004869963828465
Chapter II Neoplasms,Leiomyoma of uterus,COL6A3,Collagen alpha-3(VI) chain,15181,433,1.60 [1.26-2.05],0.0001542820397525
Chapter II Neoplasms,Leiomyoma of uterus,COL9A1,Collagen alpha-1(IX) chain,14972,425,0.64 [0.52-0.80],7.465832967653637e-05
Chapter II Neoplasms,Leiomyoma of uterus,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",12652,351,0.74 [0.57-0.96],0.0230051403421999
Chapter II Neoplasms,Leiomyoma of uterus,CPA2,Carboxypeptidase A2,15063,428,0.79 [0.69-0.90],0.0005977397856763
Chapter II Neoplasms,Leiomyoma of uterus,CPA4,Carboxypeptidase A4,12444,344,1.59 [1.25-2.02],0.0001794513380927
Chapter II Neoplasms,Leiomyoma of uterus,CPB2,Carboxypeptidase B2,12997,357,0.51 [0.33-0.79],0.002782411485158
Chapter II Neoplasms,Leiomyoma of uterus,CPM,Carboxypeptidase M,15056,423,0.59 [0.47-0.75],9.053173088798512e-06
Chapter II Neoplasms,Leiomyoma of uterus,CRH,Corticoliberin,14608,414,0.87 [0.79-0.97],0.0091165282801968
Chapter II Neoplasms,Leiomyoma of uterus,CRHBP,Corticotropin-releasing factor-binding protein,14993,419,0.45 [0.34-0.59],1.4581433513865154e-08
Chapter II Neoplasms,Leiomyoma of uterus,CRISP2,Cysteine-rich secretory protein 2,15123,428,1.16 [1.01-1.34],0.0397182682455139
Chapter II Neoplasms,Leiomyoma of uterus,CRLF1,Cytokine receptor-like factor 1,15068,428,2.49 [1.83-3.39],6.982023819996353e-09
Chapter II Neoplasms,Leiomyoma of uterus,CRTAC1,Cartilage acidic protein 1,15181,433,0.69 [0.53-0.91],0.009208874983796
Chapter II Neoplasms,Leiomyoma of uterus,CRX,Cone-rod homeobox protein,14726,419,0.91 [0.83-0.99],0.0312801572279898
Chapter II Neoplasms,Leiomyoma of uterus,CSPG4,Chondroitin sulfate proteoglycan 4,12985,359,1.42 [1.05-1.92],0.0208963372264902
Chapter II Neoplasms,Leiomyoma of uterus,CST3,Cystatin-C,14999,432,0.55 [0.40-0.77],0.0003550798231864
Chapter II Neoplasms,Leiomyoma of uterus,CTNNA1,Catenin alpha-1,12613,341,1.28 [1.02-1.62],0.0361571841366384
Chapter II Neoplasms,Leiomyoma of uterus,CTSD,Cathepsin D,13948,398,0.69 [0.54-0.90],0.0057554403556977
Chapter II Neoplasms,Leiomyoma of uterus,CTSV,Cathepsin L2,15082,428,1.32 [1.10-1.58],0.002576978475041
Chapter II Neoplasms,Leiomyoma of uterus,CXCL1,Growth-regulated alpha protein,14960,424,1.11 [1.02-1.20],0.0163477947012537
Chapter II Neoplasms,Leiomyoma of uterus,CXCL13,C-X-C motif chemokine 13,15124,428,1.17 [1.05-1.31],0.0043858459535764
Chapter II Neoplasms,Leiomyoma of uterus,CXCL16,C-X-C motif chemokine 16,15150,433,0.52 [0.36-0.75],0.0005137567047014
Chapter II Neoplasms,Leiomyoma of uterus,CYB5R2,NADH-cytochrome b5 reductase 2,12785,349,0.83 [0.70-1.00],0.0470944472746329
Chapter II Neoplasms,Leiomyoma of uterus,DCN,Decorin,14726,419,1.90 [1.31-2.76],0.0006980304272028
Chapter II Neoplasms,Leiomyoma of uterus,DCTPP1,dCTP pyrophosphatase 1,14989,424,0.74 [0.57-0.96],0.0237066010386429
Chapter II Neoplasms,Leiomyoma of uterus,DCXR,L-xylulose reductase,15038,426,0.84 [0.71-1.00],0.0447981564435847
Chapter II Neoplasms,Leiomyoma of uterus,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",14932,422,0.72 [0.59-0.88],0.0015726608003227
Chapter II Neoplasms,Leiomyoma of uterus,DDC,Aromatic-L-amino-acid decarboxylase,14967,423,0.84 [0.71-1.00],0.0470898522903697
Chapter II Neoplasms,Leiomyoma of uterus,DDI2,Protein DDI1 homolog 2,12715,355,0.86 [0.76-0.98],0.0280427291506587
Chapter II Neoplasms,Leiomyoma of uterus,DDT,D-dopachrome decarboxylase,12985,359,0.72 [0.55-0.92],0.0104838099499279
Chapter II Neoplasms,Leiomyoma of uterus,DDX39A,ATP-dependent RNA helicase DDX39A,12645,344,0.56 [0.33-0.93],0.0261994895674964
Chapter II Neoplasms,Leiomyoma of uterus,DEFB118,Beta-defensin 118,12613,341,0.76 [0.61-0.96],0.0237600919379179
Chapter II Neoplasms,Leiomyoma of uterus,DENND2B,DENN domain-containing protein 2B,12603,340,1.24 [1.07-1.45],0.0054202753314713
Chapter II Neoplasms,Leiomyoma of uterus,DKK3,Dickkopf-related protein 3,15181,433,0.70 [0.52-0.94],0.0185011040773579
Chapter II Neoplasms,Leiomyoma of uterus,DLK1,Protein delta homolog 1,15181,433,0.72 [0.62-0.84],3.408292530190077e-05
Chapter II Neoplasms,Leiomyoma of uterus,DMD,Dystrophin,12652,351,0.73 [0.58-0.91],0.0048254215230255
Chapter II Neoplasms,Leiomyoma of uterus,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,15040,428,0.81 [0.69-0.96],0.0118556086577451
Chapter II Neoplasms,Leiomyoma of uterus,DPP4,Dipeptidyl peptidase 4,14679,423,0.41 [0.31-0.55],1.408503756287791e-09
Chapter II Neoplasms,Leiomyoma of uterus,DPP6,Dipeptidyl aminopeptidase-like protein 6,14932,422,1.49 [1.15-1.93],0.0022740472429537
Chapter II Neoplasms,Leiomyoma of uterus,DPT,Dermatopontin,15181,433,0.62 [0.46-0.83],0.0013858819255085
Chapter II Neoplasms,Leiomyoma of uterus,DSC2,Desmocollin-2,14819,419,0.62 [0.47-0.80],0.0003048859535891
Chapter II Neoplasms,Leiomyoma of uterus,DSCAM,Down syndrome cell adhesion molecule,12991,362,0.75 [0.57-1.00],0.0469040104615813
Chapter II Neoplasms,Leiomyoma of uterus,DSG4,Desmoglein-4,14877,421,0.80 [0.68-0.95],0.008446075686073
Chapter II Neoplasms,Leiomyoma of uterus,DTYMK,Thymidylate kinase,13013,361,0.86 [0.75-1.00],0.046791775649341
Chapter II Neoplasms,Leiomyoma of uterus,DYNLT1,Dynein light chain Tctex-type 1,12629,354,0.84 [0.73-0.96],0.0132342099780246
Chapter II Neoplasms,Leiomyoma of uterus,EBI3_IL27,Interleukin-27,15101,425,1.31 [1.04-1.65],0.023412027627368
Chapter II Neoplasms,Leiomyoma of uterus,EDA2R,Tumor necrosis factor receptor superfamily member 27,15123,428,1.45 [1.13-1.85],0.0032971428261888
Chapter II Neoplasms,Leiomyoma of uterus,EDAR,Tumor necrosis factor receptor superfamily member EDAR,14972,425,0.86 [0.78-0.94],0.0009131655104942
Chapter II Neoplasms,Leiomyoma of uterus,EGFR,Epidermal growth factor receptor,15181,433,0.58 [0.34-0.97],0.0376764157884715
Chapter II Neoplasms,Leiomyoma of uterus,ENG,Endoglin,15181,433,0.49 [0.30-0.81],0.0051908590001176
Chapter II Neoplasms,Leiomyoma of uterus,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,15181,433,0.51 [0.37-0.69],1.1028780748580951e-05
Chapter II Neoplasms,Leiomyoma of uterus,EPO,Erythropoietin,14972,425,1.31 [1.21-1.41],2.283789257875437e-12
Chapter II Neoplasms,Leiomyoma of uterus,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,15099,427,0.62 [0.46-0.83],0.0013236579920199
Chapter II Neoplasms,Leiomyoma of uterus,ERBB3,Receptor tyrosine-protein kinase erbB-3,14936,420,0.48 [0.31-0.76],0.0018413670930838
Chapter II Neoplasms,Leiomyoma of uterus,ERC2,ERC protein 2,12629,354,0.84 [0.72-0.98],0.0251946342071447
Chapter II Neoplasms,Leiomyoma of uterus,ESAM,Endothelial cell-selective adhesion molecule,15181,433,0.70 [0.53-0.92],0.0115691893645419
Chapter II Neoplasms,Leiomyoma of uterus,EZR,Ezrin,15124,428,0.64 [0.44-0.91],0.0133612964015926
Chapter II Neoplasms,Leiomyoma of uterus,F3,Tissue factor,15030,424,0.62 [0.45-0.84],0.0019684861637707
Chapter II Neoplasms,Leiomyoma of uterus,F7,Coagulation factor VII,14998,432,0.72 [0.55-0.95],0.0190159629068546
Chapter II Neoplasms,Leiomyoma of uterus,F9,Coagulation factor IX,15001,431,0.37 [0.24-0.57],7.018968790796727e-06
Chapter II Neoplasms,Leiomyoma of uterus,FABP1,"Fatty acid-binding protein, liver",14993,419,0.88 [0.80-0.97],0.0076774593627624
Chapter II Neoplasms,Leiomyoma of uterus,FABP4,"Fatty acid-binding protein, adipocyte",15181,433,0.67 [0.56-0.80],9.963757894101504e-06
Chapter II Neoplasms,Leiomyoma of uterus,FAM3C,Protein FAM3C,14967,423,0.70 [0.52-0.94],0.0165203208765855
Chapter II Neoplasms,Leiomyoma of uterus,FAS,Tumor necrosis factor receptor superfamily member 6,15125,433,0.48 [0.35-0.67],1.0806152355148838e-05
Chapter II Neoplasms,Leiomyoma of uterus,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,13013,361,0.84 [0.73-0.97],0.0152159202511422
Chapter II Neoplasms,Leiomyoma of uterus,FCAR,Immunoglobulin alpha Fc receptor,14972,425,1.24 [1.04-1.49],0.0187544133691875
Chapter II Neoplasms,Leiomyoma of uterus,FCER2,Low affinity immunoglobulin epsilon Fc receptor,14985,426,0.78 [0.65-0.94],0.0084499712178105
Chapter II Neoplasms,Leiomyoma of uterus,FCN2,Ficolin-2,14908,428,0.76 [0.64-0.89],0.0008436353208456
Chapter II Neoplasms,Leiomyoma of uterus,FETUB,Fetuin-B,15001,431,0.79 [0.63-0.98],0.0361452565041645
Chapter II Neoplasms,Leiomyoma of uterus,FGA,Fibrinogen alpha chain,12712,352,0.68 [0.49-0.95],0.0231704980328518
Chapter II Neoplasms,Leiomyoma of uterus,FGF20,Fibroblast growth factor 20,12645,344,0.67 [0.50-0.90],0.0079795159447096
Chapter II Neoplasms,Leiomyoma of uterus,FGF23,Fibroblast growth factor 23,15099,428,1.47 [1.36-1.59],8.0703319955279875e-22
Chapter II Neoplasms,Leiomyoma of uterus,FGF5,Fibroblast growth factor 5,14692,416,0.71 [0.54-0.93],0.0127553187265715
Chapter II Neoplasms,Leiomyoma of uterus,FGFBP3,Fibroblast growth factor-binding protein 3,12968,358,1.37 [1.05-1.78],0.0197165998599915
Chapter II Neoplasms,Leiomyoma of uterus,FGFR2,Fibroblast growth factor receptor 2,15038,426,0.55 [0.37-0.81],0.0027872798321668
Chapter II Neoplasms,Leiomyoma of uterus,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,14888,417,1.50 [1.11-2.04],0.0088289750964837
Chapter II Neoplasms,Leiomyoma of uterus,FLT3LG,Fms-related tyrosine kinase 3 ligand,15157,428,0.63 [0.49-0.82],0.0005125199284632
Chapter II Neoplasms,Leiomyoma of uterus,FOS,Proto-oncogene c-Fos,12523,338,1.47 [1.10-1.97],0.0100229202235198
Chapter II Neoplasms,Leiomyoma of uterus,FSHB,Follitropin subunit beta,12652,351,0.50 [0.43-0.59],2.890835645943016e-17
Chapter II Neoplasms,Leiomyoma of uterus,FSTL1,Follistatin-related protein 1,12652,351,1.77 [1.14-2.74],0.0112230844734017
Chapter II Neoplasms,Leiomyoma of uterus,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,15124,428,0.79 [0.65-0.95],0.0123189347496953
Chapter II Neoplasms,Leiomyoma of uterus,GART,Trifunctional purine biosynthetic protein adenosine-3,12991,362,0.50 [0.32-0.79],0.0025981876874389
Chapter II Neoplasms,Leiomyoma of uterus,GFRAL,GDNF family receptor alpha-like,12581,346,0.79 [0.66-0.93],0.0062218858438233
Chapter II Neoplasms,Leiomyoma of uterus,GGT5,Glutathione hydrolase 5 proenzyme,14888,417,0.69 [0.48-0.99],0.0436076345335641
Chapter II Neoplasms,Leiomyoma of uterus,GIGYF2,GRB10-interacting GYF protein 2,12991,362,0.86 [0.75-0.98],0.0233564446407597
Chapter II Neoplasms,Leiomyoma of uterus,GIP,Gastric inhibitory polypeptide,12652,351,0.75 [0.58-0.96],0.0250558802773293
Chapter II Neoplasms,Leiomyoma of uterus,GIPC2,PDZ domain-containing protein GIPC2,12968,358,0.59 [0.41-0.84],0.0039717252538636
Chapter II Neoplasms,Leiomyoma of uterus,GLRX,Glutaredoxin-1,14908,422,0.83 [0.71-0.96],0.0143973886254264
Chapter II Neoplasms,Leiomyoma of uterus,GMPR,GMP reductase 1,15157,428,0.83 [0.71-0.97],0.0231982637644285
Chapter II Neoplasms,Leiomyoma of uterus,GNPDA1,Glucosamine-6-phosphate isomerase 1,12652,351,0.60 [0.41-0.87],0.0066029864794967
Chapter II Neoplasms,Leiomyoma of uterus,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,14538,415,1.18 [1.08-1.30],0.0003443492518185
Chapter II Neoplasms,Leiomyoma of uterus,GPR15L,Protein GPR15L,12947,357,0.84 [0.72-0.99],0.0331672800796821
Chapter II Neoplasms,Leiomyoma of uterus,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,13013,361,0.83 [0.71-0.96],0.0149775761461688
Chapter II Neoplasms,Leiomyoma of uterus,GSN,Gelsolin,12967,360,0.59 [0.35-0.98],0.0411361191715575
Chapter II Neoplasms,Leiomyoma of uterus,GSR,"Glutathione reductase, mitochondrial",12940,359,0.38 [0.24-0.61],3.95105248482501e-05
Chapter II Neoplasms,Leiomyoma of uterus,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,12748,354,0.84 [0.71-0.99],0.0405969454264605
Chapter II Neoplasms,Leiomyoma of uterus,GUSB,Beta-glucuronidase,15049,430,0.86 [0.74-1.00],0.0469847120783071
Chapter II Neoplasms,Leiomyoma of uterus,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",15084,425,0.86 [0.76-0.96],0.0086589449288284
Chapter II Neoplasms,Leiomyoma of uterus,HAO1,Hydroxyacid oxidase 1,15123,428,0.93 [0.87-0.99],0.0231329517062791
Chapter II Neoplasms,Leiomyoma of uterus,HAVCR1,Hepatitis A virus cellular receptor 1,15106,428,0.83 [0.71-0.96],0.0118003248041175
Chapter II Neoplasms,Leiomyoma of uterus,HBZ,Hemoglobin subunit zeta,13013,361,0.86 [0.78-0.95],0.0029384710382672
Chapter II Neoplasms,Leiomyoma of uterus,HDDC2,5'-deoxynucleotidase HDDC2,12947,357,0.73 [0.58-0.93],0.0097091073450671
Chapter II Neoplasms,Leiomyoma of uterus,HEG1,Protein HEG homolog 1,12715,355,0.62 [0.42-0.90],0.0128022688644712
Chapter II Neoplasms,Leiomyoma of uterus,HEPACAM2,HEPACAM family member 2,12968,358,1.30 [1.02-1.66],0.032799222161264
Chapter II Neoplasms,Leiomyoma of uterus,HEPH,Hephaestin,13013,361,3.38 [2.31-4.94],3.1815905644299227e-10
Chapter II Neoplasms,Leiomyoma of uterus,HMBS,Porphobilinogen deaminase,15123,428,0.75 [0.63-0.89],0.0013994855802311
Chapter II Neoplasms,Leiomyoma of uterus,HMOX1,Heme oxygenase 1,14820,418,0.60 [0.49-0.72],1.6635454086501014e-07
Chapter II Neoplasms,Leiomyoma of uterus,HPGDS,Hematopoietic prostaglandin D synthase,14633,414,0.79 [0.62-1.00],0.0490877211097708
Chapter II Neoplasms,Leiomyoma of uterus,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,12652,351,1.31 [1.04-1.67],0.0236402835874339
Chapter II Neoplasms,Leiomyoma of uterus,HSPA1A,Heat shock 70 kDa protein 1A,15040,428,0.88 [0.78-0.99],0.0408001965462381
Chapter II Neoplasms,Leiomyoma of uterus,HYAL1,Hyaluronidase-1,14873,424,0.56 [0.39-0.82],0.0025132674502688
Chapter II Neoplasms,Leiomyoma of uterus,HYOU1,Hypoxia up-regulated protein 1,15181,433,0.50 [0.33-0.74],0.0005374079954097
Chapter II Neoplasms,Leiomyoma of uterus,ICAM1,Intercellular adhesion molecule 1,14911,430,0.65 [0.48-0.88],0.0052244387841713
Chapter II Neoplasms,Leiomyoma of uterus,IFT20,Intraflagellar transport protein 20 homolog,12629,354,0.77 [0.60-0.99],0.0413672761039374
Chapter II Neoplasms,Leiomyoma of uterus,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,12985,359,1.69 [1.16-2.48],0.006660686143401
Chapter II Neoplasms,Leiomyoma of uterus,IGFBP3,Insulin-like growth factor-binding protein 3,15023,432,0.72 [0.53-0.98],0.0380356137711648
Chapter II Neoplasms,Leiomyoma of uterus,IGLC2,Immunoglobulin lambda constant 2,13003,358,0.56 [0.32-0.96],0.0355348162914096
Chapter II Neoplasms,Leiomyoma of uterus,IL10,Interleukin-10,14692,416,1.11 [1.01-1.22],0.0312158242356423
Chapter II Neoplasms,Leiomyoma of uterus,IL12RB1,Interleukin-12 receptor subunit beta-1,14692,416,0.77 [0.61-0.98],0.0338006073421773
Chapter II Neoplasms,Leiomyoma of uterus,IL13RA1,Interleukin-13 receptor subunit alpha-1,14802,419,0.67 [0.46-0.98],0.040267739845052
Chapter II Neoplasms,Leiomyoma of uterus,IL15RA,Interleukin-15 receptor subunit alpha,14692,416,0.75 [0.59-0.96],0.0224076686021043
Chapter II Neoplasms,Leiomyoma of uterus,IL18,Interleukin-18,14942,418,0.78 [0.65-0.94],0.0085589648261818
Chapter II Neoplasms,Leiomyoma of uterus,IL1B,Interleukin-1 beta,14617,415,0.82 [0.70-0.96],0.0142216693260886
Chapter II Neoplasms,Leiomyoma of uterus,IL2RA,Interleukin-2 receptor subunit alpha,14883,427,0.72 [0.57-0.90],0.00412696278692
Chapter II Neoplasms,Leiomyoma of uterus,IL31RA,Interleukin-31 receptor subunit alpha,12595,343,0.57 [0.44-0.75],3.7539808077663e-05
Chapter II Neoplasms,Leiomyoma of uterus,IL32,Interleukin-32,14972,425,0.76 [0.62-0.94],0.010187199325185
Chapter II Neoplasms,Leiomyoma of uterus,IL6R,Interleukin-6 receptor subunit alpha,14879,430,0.75 [0.58-0.96],0.0239723325509425
Chapter II Neoplasms,Leiomyoma of uterus,IL6ST,Interleukin-6 receptor subunit beta,14989,424,0.61 [0.38-0.99],0.0457377850259845
Chapter II Neoplasms,Leiomyoma of uterus,INPP1,Inositol polyphosphate 1-phosphatase,14932,422,0.84 [0.72-0.98],0.029193278645642
Chapter II Neoplasms,Leiomyoma of uterus,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,14397,404,0.76 [0.60-0.96],0.0228522169131073
Chapter II Neoplasms,Leiomyoma of uterus,ITGA11,Integrin alpha-11,14972,425,0.72 [0.56-0.92],0.0079812542606017
Chapter II Neoplasms,Leiomyoma of uterus,ITGA2,Integrin alpha-2,12715,355,0.70 [0.52-0.94],0.0196134365855251
Chapter II Neoplasms,Leiomyoma of uterus,ITGB1,Integrin beta-1,14949,431,0.61 [0.41-0.91],0.0150600162774639
Chapter II Neoplasms,Leiomyoma of uterus,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,13027,358,0.68 [0.47-0.99],0.0468124279688848
Chapter II Neoplasms,Leiomyoma of uterus,JAM2,Junctional adhesion molecule B,15124,428,0.53 [0.37-0.75],0.0003706824619183
Chapter II Neoplasms,Leiomyoma of uterus,KDR,Vascular endothelial growth factor receptor 2,15038,426,0.60 [0.45-0.79],0.0003582620797259
Chapter II Neoplasms,Leiomyoma of uterus,KIAA0319,Dyslexia-associated protein KIAA0319,12968,358,0.61 [0.43-0.86],0.0047399626188193
Chapter II Neoplasms,Leiomyoma of uterus,KIF20B,Kinesin-like protein KIF20B,12613,341,1.13 [1.00-1.27],0.0423026793285575
Chapter II Neoplasms,Leiomyoma of uterus,KLK4,Kallikrein-4,15123,428,1.50 [1.34-1.69],1.5612430595817073e-11
Chapter II Neoplasms,Leiomyoma of uterus,KLKB1,Plasma kallikrein,12771,347,0.66 [0.44-0.97],0.0348181565631029
Chapter II Neoplasms,Leiomyoma of uterus,KRT18,"Keratin, type I cytoskeletal 18",14932,422,0.83 [0.74-0.93],0.001984369023413
Chapter II Neoplasms,Leiomyoma of uterus,KRT19,"Keratin, type I cytoskeletal 19",14953,425,0.83 [0.72-0.96],0.0096191674961013
Chapter II Neoplasms,Leiomyoma of uterus,KYNU,Kynureninase,15157,428,0.74 [0.61-0.89],0.0018469479974181
Chapter II Neoplasms,Leiomyoma of uterus,LCAT,Phosphatidylcholine-sterol acyltransferase,13019,364,0.58 [0.37-0.90],0.0159405869035366
Chapter II Neoplasms,Leiomyoma of uterus,LEFTY2,Left-right determination factor 2,15101,425,2.57 [2.28-2.89],1.6780103461898458e-55
Chapter II Neoplasms,Leiomyoma of uterus,LEPR,Leptin receptor,14989,424,0.69 [0.52-0.93],0.0136905030675161
Chapter II Neoplasms,Leiomyoma of uterus,LGALS3,Galectin-3,15031,430,0.65 [0.49-0.86],0.0026038340700733
Chapter II Neoplasms,Leiomyoma of uterus,LGALS4,Galectin-4,14993,419,0.75 [0.63-0.89],0.0008152620732315
Chapter II Neoplasms,Leiomyoma of uterus,LGALS9,Galectin-9,14987,425,0.75 [0.58-0.98],0.0377374741229899
Chapter II Neoplasms,Leiomyoma of uterus,LHB,Lutropin subunit beta,14633,414,0.85 [0.76-0.95],0.0035141697878036
Chapter II Neoplasms,Leiomyoma of uterus,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,15017,428,0.83 [0.72-0.96],0.0115129608637649
Chapter II Neoplasms,Leiomyoma of uterus,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,14967,423,0.76 [0.58-0.99],0.0427392448735947
Chapter II Neoplasms,Leiomyoma of uterus,LMOD1,Leiomodin-1,12991,362,1.51 [1.23-1.85],9.881850517469768e-05
Chapter II Neoplasms,Leiomyoma of uterus,LPA,Apolipoprotein(a),12702,348,1.08 [1.01-1.14],0.0162674735721472
Chapter II Neoplasms,Leiomyoma of uterus,LPL,Lipoprotein lipase,14989,424,0.78 [0.66-0.93],0.0055518153926016
Chapter II Neoplasms,Leiomyoma of uterus,LRP1,Prolow-density lipoprotein receptor-related protein 1,14932,422,1.39 [1.02-1.90],0.0388622446460069
Chapter II Neoplasms,Leiomyoma of uterus,LTBP2,Latent-transforming growth factor beta-binding protein 2,15181,433,2.07 [1.61-2.67],1.9794639198830225e-08
Chapter II Neoplasms,Leiomyoma of uterus,LYAR,Cell growth-regulating nucleolar protein,14633,414,0.77 [0.64-0.94],0.0100057496764252
Chapter II Neoplasms,Leiomyoma of uterus,LYZL2,Lysozyme-like protein 2,12547,340,0.70 [0.51-0.96],0.0260867569593363
Chapter II Neoplasms,Leiomyoma of uterus,MAEA,E3 ubiquitin-protein transferase MAEA,14633,414,0.76 [0.60-0.96],0.0234490203258701
Chapter II Neoplasms,Leiomyoma of uterus,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",12547,340,0.78 [0.64-0.96],0.0215180091768859
Chapter II Neoplasms,Leiomyoma of uterus,MAP2,Microtubule-associated protein 2,12968,358,0.79 [0.63-0.99],0.0435884439275424
Chapter II Neoplasms,Leiomyoma of uterus,MATN2,Matrilin-2,15020,420,2.09 [1.58-2.77],2.14203754064655e-07
Chapter II Neoplasms,Leiomyoma of uterus,MATN3,Matrilin-3,14863,416,1.49 [1.15-1.93],0.0025045611875016
Chapter II Neoplasms,Leiomyoma of uterus,MCEMP1,Mast cell-expressed membrane protein 1,12645,344,0.88 [0.78-0.99],0.0272127700449645
Chapter II Neoplasms,Leiomyoma of uterus,MDK,Midkine,14990,424,1.29 [1.11-1.50],0.0010517305482672
Chapter II Neoplasms,Leiomyoma of uterus,MEGF9,Multiple epidermal growth factor-like domains protein 9,15125,433,0.47 [0.32-0.70],0.0001592416094602
Chapter II Neoplasms,Leiomyoma of uterus,MELTF,Melanotransferrin,13013,361,1.73 [1.25-2.40],0.0010353710032985
Chapter II Neoplasms,Leiomyoma of uterus,MEP1A,Meprin A subunit alpha,12947,357,0.84 [0.72-0.97],0.0198603152505957
Chapter II Neoplasms,Leiomyoma of uterus,MET,Hepatocyte growth factor receptor,15040,429,0.38 [0.25-0.59],1.1128596087270002e-05
Chapter II Neoplasms,Leiomyoma of uterus,MFAP3L,Microfibrillar-associated protein 3-like,12629,354,0.81 [0.67-0.98],0.026930514394963
Chapter II Neoplasms,Leiomyoma of uterus,MFAP4,Microfibril-associated glycoprotein 4,12715,355,1.42 [1.03-1.95],0.0314790061171027
Chapter II Neoplasms,Leiomyoma of uterus,MFAP5,Microfibrillar-associated protein 5,15181,433,1.69 [1.38-2.06],3.060102165409313e-07
Chapter II Neoplasms,Leiomyoma of uterus,MMP10,Stromelysin-2,14981,417,1.46 [1.29-1.64],4.85567517767183e-10
Chapter II Neoplasms,Leiomyoma of uterus,MMP9,Matrix metalloproteinase-9,14962,423,0.86 [0.75-0.98],0.0283406616198748
Chapter II Neoplasms,Leiomyoma of uterus,MNAT1,CDK-activating kinase assembly factor MAT1,12748,354,0.77 [0.60-0.98],0.0375963483398002
Chapter II Neoplasms,Leiomyoma of uterus,MORF4L2,Mortality factor 4-like protein 2,12547,340,0.72 [0.52-1.00],0.0488953280142835
Chapter II Neoplasms,Leiomyoma of uterus,MRC1,Macrophage mannose receptor 1,13019,364,0.69 [0.48-0.99],0.0419944598600578
Chapter II Neoplasms,Leiomyoma of uterus,MSLNL,Mesothelin-like protein,12629,354,0.73 [0.55-0.98],0.0362219919401148
Chapter II Neoplasms,Leiomyoma of uterus,MUC16,Mucin-16,14932,422,1.14 [1.08-1.20],1.8877243910182927e-06
Chapter II Neoplasms,Leiomyoma of uterus,MYH4,Myosin-4,12603,340,1.35 [1.14-1.58],0.0003256620110677
Chapter II Neoplasms,Leiomyoma of uterus,NBL1,Neuroblastoma suppressor of tumorigenicity 1,15038,426,2.22 [1.61-3.05],1.1744307803444743e-06
Chapter II Neoplasms,Leiomyoma of uterus,NCS1,Neuronal calcium sensor 1,15123,428,1.67 [1.25-2.24],0.0005823537543761
Chapter II Neoplasms,Leiomyoma of uterus,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,12940,359,1.15 [1.02-1.31],0.025599019644236
Chapter II Neoplasms,Leiomyoma of uterus,NECTIN2,Nectin-2,14967,423,0.67 [0.49-0.91],0.0115567784526484
Chapter II Neoplasms,Leiomyoma of uterus,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,12645,344,0.80 [0.65-0.98],0.0323567508091887
Chapter II Neoplasms,Leiomyoma of uterus,NEDD9,Enhancer of filamentation 1,12645,344,0.66 [0.47-0.94],0.0209220304045239
Chapter II Neoplasms,Leiomyoma of uterus,NELL1,Protein kinase C-binding protein NELL1,15038,426,0.81 [0.66-0.99],0.0440454510513813
Chapter II Neoplasms,Leiomyoma of uterus,NLGN1,Neuroligin-1,12629,354,0.83 [0.70-0.99],0.0387279914316474
Chapter II Neoplasms,Leiomyoma of uterus,NOMO1,Nodal modulator 1,14985,426,0.58 [0.41-0.83],0.0031761701450652
Chapter II Neoplasms,Leiomyoma of uterus,NOS3,"Nitric oxide synthase, endothelial",14612,411,1.23 [1.07-1.41],0.0030469004966691
Chapter II Neoplasms,Leiomyoma of uterus,NOTCH1,Neurogenic locus notch homolog protein 1,15181,433,0.56 [0.32-0.97],0.038793880272826
Chapter II Neoplasms,Leiomyoma of uterus,NOTCH3,Neurogenic locus notch homolog protein 3,15181,433,1.48 [1.17-1.86],0.0010910567106972
Chapter II Neoplasms,Leiomyoma of uterus,NPDC1,Neural proliferation differentiation and control protein 1,14989,424,0.68 [0.50-0.93],0.0159380286869185
Chapter II Neoplasms,Leiomyoma of uterus,NPL,N-acetylneuraminate lyase,13013,361,0.72 [0.57-0.91],0.0066463439124947
Chapter II Neoplasms,Leiomyoma of uterus,NRP2,Neuropilin-2,14985,426,1.52 [1.15-2.00],0.0028438472643529
Chapter II Neoplasms,Leiomyoma of uterus,NRXN3,Neurexin-3,12629,354,0.68 [0.48-0.96],0.0269513659772897
Chapter II Neoplasms,Leiomyoma of uterus,NT5C1A,Cytosolic 5'-nucleotidase 1A,12968,358,1.34 [1.03-1.74],0.0307850482547713
Chapter II Neoplasms,Leiomyoma of uterus,NTF3,Neurotrophin-3,14972,425,0.68 [0.52-0.87],0.0023295405163984
Chapter II Neoplasms,Leiomyoma of uterus,NTF4,Neurotrophin-4,14633,414,1.34 [1.16-1.55],8.536655707544604e-05
Chapter II Neoplasms,Leiomyoma of uterus,NTRK2,BDNF/NT-3 growth factors receptor,14989,424,0.67 [0.48-0.93],0.0159504107369344
Chapter II Neoplasms,Leiomyoma of uterus,OBP2B,Odorant-binding protein 2b,14839,416,1.24 [1.10-1.40],0.0006342293496334
Chapter II Neoplasms,Leiomyoma of uterus,OCLN,Occludin,12991,362,0.67 [0.53-0.85],0.0011079366193614
Chapter II Neoplasms,Leiomyoma of uterus,OFD1,Oral-facial-digital syndrome 1 protein,12748,354,1.14 [1.01-1.29],0.0394825663269885
Chapter II Neoplasms,Leiomyoma of uterus,OGFR,Opioid growth factor receptor,14932,422,0.74 [0.57-0.96],0.023467592843057
Chapter II Neoplasms,Leiomyoma of uterus,OGN,Mimecan,14985,426,1.72 [1.39-2.12],3.975795406955305e-07
Chapter II Neoplasms,Leiomyoma of uterus,OLFM4,Olfactomedin-4,12233,337,0.91 [0.83-0.98],0.0184312168528115
Chapter II Neoplasms,Leiomyoma of uterus,OSM,Oncostatin-M,14892,424,0.87 [0.77-0.97],0.0133881876023588
Chapter II Neoplasms,Leiomyoma of uterus,OSMR,Oncostatin-M-specific receptor subunit beta,15054,432,0.62 [0.42-0.92],0.0185195796307303
Chapter II Neoplasms,Leiomyoma of uterus,PAEP,Glycodelin,14888,417,1.32 [1.25-1.39],6.59157003923887e-27
Chapter II Neoplasms,Leiomyoma of uterus,PAXX,Protein PAXX,12715,355,0.78 [0.62-0.98],0.0296752513915915
Chapter II Neoplasms,Leiomyoma of uterus,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,12685,353,0.77 [0.61-0.98],0.0301115666187691
Chapter II Neoplasms,Leiomyoma of uterus,PCDH12,Protocadherin-12,12991,362,0.63 [0.42-0.93],0.020346227958236
Chapter II Neoplasms,Leiomyoma of uterus,PCSK9,Proprotein convertase subtilisin/kexin type 9,15181,433,0.72 [0.58-0.89],0.0024022243482413
Chapter II Neoplasms,Leiomyoma of uterus,PDCD1,Programmed cell death protein 1,15101,428,0.70 [0.56-0.87],0.0010986043712503
Chapter II Neoplasms,Leiomyoma of uterus,PDIA5,Protein disulfide-isomerase A5,12547,340,0.79 [0.66-0.95],0.0139542697162864
Chapter II Neoplasms,Leiomyoma of uterus,PECAM1,Platelet endothelial cell adhesion molecule,14985,426,0.75 [0.56-1.00],0.0494896492949795
Chapter II Neoplasms,Leiomyoma of uterus,PEPD,Xaa-Pro dipeptidase,13019,364,0.52 [0.35-0.75],0.0006447248060041
Chapter II Neoplasms,Leiomyoma of uterus,PHLDB2,Pleckstrin homology-like domain family B member 2,12547,340,0.87 [0.77-0.99],0.0344249739528316
Chapter II Neoplasms,Leiomyoma of uterus,PI16,Peptidase inhibitor 16,13019,364,0.51 [0.34-0.77],0.0012934376367176
Chapter II Neoplasms,Leiomyoma of uterus,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,14972,425,0.75 [0.65-0.87],7.473231187474523e-05
Chapter II Neoplasms,Leiomyoma of uterus,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,14985,426,0.69 [0.48-0.97],0.033095292743203
Chapter II Neoplasms,Leiomyoma of uterus,PLA2G2A,"Phospholipase A2, membrane associated",14957,428,0.84 [0.72-0.98],0.0311705214917696
Chapter II Neoplasms,Leiomyoma of uterus,PLG,Plasminogen,12681,348,0.56 [0.36-0.87],0.0103688244527407
Chapter II Neoplasms,Leiomyoma of uterus,PLIN3,Perilipin-3,14989,424,0.80 [0.65-0.98],0.0302766164552618
Chapter II Neoplasms,Leiomyoma of uterus,PODXL2,Podocalyxin-like protein 2,15038,426,0.65 [0.48-0.88],0.0047697414144637
Chapter II Neoplasms,Leiomyoma of uterus,POF1B,Protein POF1B,12645,344,0.72 [0.56-0.93],0.0126423263366069
Chapter II Neoplasms,Leiomyoma of uterus,POSTN,Periostin,12985,359,1.51 [1.18-1.94],0.0011143143134268
Chapter II Neoplasms,Leiomyoma of uterus,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,12991,362,0.68 [0.51-0.92],0.0127576343220408
Chapter II Neoplasms,Leiomyoma of uterus,PRCP,Lysosomal Pro-X carboxypeptidase,15075,428,0.67 [0.51-0.89],0.0046110553981261
Chapter II Neoplasms,Leiomyoma of uterus,PRDX2,Peroxiredoxin-2,12795,358,0.82 [0.70-0.97],0.018958822082241
Chapter II Neoplasms,Leiomyoma of uterus,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,14692,416,0.84 [0.71-0.99],0.0395371274695478
Chapter II Neoplasms,Leiomyoma of uterus,PRL,Prolactin,15124,428,1.29 [1.17-1.42],1.800393589902309e-07
Chapter II Neoplasms,Leiomyoma of uterus,PRND,Prion-like protein doppel,12968,358,1.66 [1.41-1.96],1.5527296433699224e-09
Chapter II Neoplasms,Leiomyoma of uterus,PROC,Vitamin K-dependent protein C,15001,431,0.42 [0.30-0.57],7.89658351395982e-08
Chapter II Neoplasms,Leiomyoma of uterus,PROK1,Prokineticin-1,14972,425,1.29 [1.17-1.42],1.4075534025822544e-07
Chapter II Neoplasms,Leiomyoma of uterus,PRSS53,Serine protease 53,12968,358,0.74 [0.57-0.95],0.020788363271812
Chapter II Neoplasms,Leiomyoma of uterus,PRSS8,Prostasin,14938,425,0.71 [0.57-0.88],0.0019168984173736
Chapter II Neoplasms,Leiomyoma of uterus,PSMG4,Proteasome assembly chaperone 4,12645,344,0.83 [0.68-1.00],0.0464195520646122
Chapter II Neoplasms,Leiomyoma of uterus,PTK7,Inactive tyrosine-protein kinase 7,14612,411,2.16 [1.85-2.51],4.652889857806639e-23
Chapter II Neoplasms,Leiomyoma of uterus,PTN,Pleiotrophin,14726,419,1.76 [1.51-2.05],8.586609843673529e-13
Chapter II Neoplasms,Leiomyoma of uterus,PTPRF,Receptor-type tyrosine-protein phosphatase F,15181,433,0.57 [0.43-0.76],0.0001344097935142
Chapter II Neoplasms,Leiomyoma of uterus,PTPRM,Receptor-type tyrosine-protein phosphatase mu,14943,423,0.65 [0.46-0.92],0.014332384939635
Chapter II Neoplasms,Leiomyoma of uterus,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,14829,417,0.74 [0.56-0.98],0.0382955412877133
Chapter II Neoplasms,Leiomyoma of uterus,PTPRR,Receptor-type tyrosine-protein phosphatase R,12968,358,0.74 [0.55-0.98],0.0384162851510518
Chapter II Neoplasms,Leiomyoma of uterus,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,13013,361,0.62 [0.45-0.84],0.0023599333908601
Chapter II Neoplasms,Leiomyoma of uterus,PVALB,Parvalbumin alpha,15062,423,0.93 [0.86-0.99],0.0310988315293377
Chapter II Neoplasms,Leiomyoma of uterus,PVR,Poliovirus receptor,15124,428,0.77 [0.62-0.97],0.0291783751111968
Chapter II Neoplasms,Leiomyoma of uterus,QDPR,Dihydropteridine reductase,14924,423,0.81 [0.67-0.98],0.0300916742746592
Chapter II Neoplasms,Leiomyoma of uterus,RBKS,Ribokinase,14630,411,0.79 [0.66-0.93],0.0063761163357448
Chapter II Neoplasms,Leiomyoma of uterus,RBM25,RNA-binding protein 25,12547,340,0.74 [0.58-0.94],0.0124332415556811
Chapter II Neoplasms,Leiomyoma of uterus,RBP5,Retinol-binding protein 5,14932,422,0.78 [0.66-0.92],0.0027659954806867
Chapter II Neoplasms,Leiomyoma of uterus,RCOR1,REST corepressor 1,14726,419,0.78 [0.62-0.99],0.0452224245780281
Chapter II Neoplasms,Leiomyoma of uterus,REG4,Regenerating islet-derived protein 4,15020,420,0.77 [0.63-0.93],0.006363228608856
Chapter II Neoplasms,Leiomyoma of uterus,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,14932,422,0.80 [0.66-0.98],0.0345300088993537
Chapter II Neoplasms,Leiomyoma of uterus,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,12603,340,0.81 [0.67-0.97],0.0193887483882093
Chapter II Neoplasms,Leiomyoma of uterus,RLN1,Prorelaxin H1,12991,362,1.08 [1.01-1.17],0.0312985480334423
Chapter II Neoplasms,Leiomyoma of uterus,RLN2,Prorelaxin H2,12696,353,1.08 [1.03-1.12],0.0003889690834422
Chapter II Neoplasms,Leiomyoma of uterus,RNASE4,Ribonuclease 4,12583,347,0.60 [0.40-0.90],0.0131327333570446
Chapter II Neoplasms,Leiomyoma of uterus,RNASE6,Ribonuclease K6,12917,358,0.62 [0.41-0.94],0.0233640464566816
Chapter II Neoplasms,Leiomyoma of uterus,RNASEH2A,Ribonuclease H2 subunit A,12991,362,0.79 [0.63-0.98],0.0345559880218572
Chapter II Neoplasms,Leiomyoma of uterus,ROBO2,Roundabout homolog 2,15124,428,0.64 [0.44-0.93],0.0200199566218858
Chapter II Neoplasms,Leiomyoma of uterus,RSPO1,R-spondin-1,14888,417,3.45 [2.79-4.26],2.3057558651086797e-30
Chapter II Neoplasms,Leiomyoma of uterus,RSPO3,R-spondin-3,15123,428,4.52 [3.52-5.80],3.7287116844301256e-32
Chapter II Neoplasms,Leiomyoma of uterus,S100G,Protein S100-G,12991,362,1.26 [1.03-1.54],0.0253425926541828
Chapter II Neoplasms,Leiomyoma of uterus,SATB1,DNA-binding protein SATB1,12991,362,0.64 [0.44-0.94],0.0235415153598811
Chapter II Neoplasms,Leiomyoma of uterus,SCARA5,Scavenger receptor class A member 5,15124,428,0.75 [0.56-1.00],0.0491182845825359
Chapter II Neoplasms,Leiomyoma of uterus,SCARB2,Lysosome membrane protein 2,14612,411,0.69 [0.50-0.96],0.0271523929432082
Chapter II Neoplasms,Leiomyoma of uterus,SCG3,Secretogranin-3,15020,420,0.75 [0.57-0.97],0.0304996613405264
Chapter II Neoplasms,Leiomyoma of uterus,SCGB3A1,Secretoglobin family 3A member 1,12715,355,0.58 [0.38-0.88],0.0107265503211295
Chapter II Neoplasms,Leiomyoma of uterus,SCGN,Secretagogin,14692,416,0.68 [0.55-0.84],0.0002749302792537
Chapter II Neoplasms,Leiomyoma of uterus,SCN4B,Sodium channel subunit beta-4,12652,351,0.74 [0.57-0.94],0.0143647900681025
Chapter II Neoplasms,Leiomyoma of uterus,SCRG1,Scrapie-responsive protein 1,13013,361,0.68 [0.46-1.00],0.0485686832743664
Chapter II Neoplasms,Leiomyoma of uterus,SCRN1,Secernin-1,14972,425,0.85 [0.73-0.99],0.0413782265312874
Chapter II Neoplasms,Leiomyoma of uterus,SDC1,Syndecan-1,14989,424,0.72 [0.58-0.91],0.0053558876553981
Chapter II Neoplasms,Leiomyoma of uterus,SDK2,Protein sidekick-2,12715,355,1.37 [1.07-1.75],0.0134256140025125
Chapter II Neoplasms,Leiomyoma of uterus,SELENOP,Selenoprotein P,13027,358,0.56 [0.35-0.89],0.0136410322998793
Chapter II Neoplasms,Leiomyoma of uterus,SELPLG,P-selectin glycoprotein ligand 1,14972,425,0.77 [0.61-0.98],0.0321972071496017
Chapter II Neoplasms,Leiomyoma of uterus,SEMA3F,Semaphorin-3F,14989,424,0.60 [0.43-0.84],0.0028199287830955
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA3,Alpha-1-antichymotrypsin,12980,355,0.33 [0.16-0.68],0.0025843489604386
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA4,Kallistatin,12776,352,0.62 [0.41-0.95],0.0293810234604038
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA5,Plasma serine protease inhibitor,12834,352,0.68 [0.49-0.95],0.0237286378522456
Chapter II Neoplasms,Leiomyoma of uterus,SERPINA9,Serpin A9,14854,421,0.79 [0.71-0.89],3.635155840783401e-05
Chapter II Neoplasms,Leiomyoma of uterus,SERPINC1,Antithrombin-III,12997,357,0.47 [0.24-0.93],0.0308207995812269
Chapter II Neoplasms,Leiomyoma of uterus,SERPINF1,Pigment epithelium-derived factor,12830,351,0.67 [0.44-1.00],0.047683157190157
Chapter II Neoplasms,Leiomyoma of uterus,SERPING1,Plasma protease C1 inhibitor,12997,357,0.58 [0.34-0.98],0.0415296296876384
Chapter II Neoplasms,Leiomyoma of uterus,SEZ6L2,Seizure 6-like protein 2,14932,422,7.55 [5.78-9.86],6.655612049033923e-50
Chapter II Neoplasms,Leiomyoma of uterus,SF3B4,Splicing factor 3B subunit 4,14932,422,0.88 [0.78-0.99],0.0315534049486286
Chapter II Neoplasms,Leiomyoma of uterus,SFRP1,Secreted frizzled-related protein 1,14833,416,2.54 [2.16-2.99],2.8407081697428606e-29
Chapter II Neoplasms,Leiomyoma of uterus,SFRP4,Secreted frizzled-related protein 4,12715,355,1.82 [1.45-2.30],3.678537629374463e-07
Chapter II Neoplasms,Leiomyoma of uterus,SFTPD,Pulmonary surfactant-associated protein D,14989,424,0.84 [0.74-0.96],0.0080073070751692
Chapter II Neoplasms,Leiomyoma of uterus,SHD,SH2 domain-containing adapter protein D,12581,339,0.85 [0.74-0.98],0.02996389353343
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC7,Sialic acid-binding Ig-like lectin 7,14989,424,0.72 [0.54-0.97],0.0300150852697682
Chapter II Neoplasms,Leiomyoma of uterus,SIGLEC8,Sialic acid-binding Ig-like lectin 8,12652,351,0.69 [0.55-0.86],0.0008396118000308
Chapter II Neoplasms,Leiomyoma of uterus,SLC28A1,Sodium/nucleoside cotransporter 1,12547,340,0.76 [0.62-0.94],0.0104193743296626
Chapter II Neoplasms,Leiomyoma of uterus,SLC39A14,Zinc transporter ZIP14,14612,411,0.70 [0.53-0.94],0.0164832111285897
Chapter II Neoplasms,Leiomyoma of uterus,SLIT2,Slit homolog 2 protein,14612,411,1.19 [1.03-1.38],0.0212667053702543
Chapter II Neoplasms,Leiomyoma of uterus,SLITRK1,SLIT and NTRK-like protein 1,12645,344,0.69 [0.50-0.96],0.026473841233592
Chapter II Neoplasms,Leiomyoma of uterus,SMOC2,SPARC-related modular calcium-binding protein 2,15068,428,2.85 [2.42-3.36],4.702217408951011e-36
Chapter II Neoplasms,Leiomyoma of uterus,SNCG,Gamma-synuclein,14888,417,0.86 [0.76-0.98],0.0260959390406963
Chapter II Neoplasms,Leiomyoma of uterus,SOD1,Superoxide dismutase [Cu-Zn],14648,417,0.80 [0.67-0.95],0.0135763668128432
Chapter II Neoplasms,Leiomyoma of uterus,SORD,Sorbitol dehydrogenase,15055,423,0.87 [0.77-0.99],0.031951813428847
Chapter II Neoplasms,Leiomyoma of uterus,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,12991,362,0.67 [0.46-0.98],0.0389475010078022
Chapter II Neoplasms,Leiomyoma of uterus,SPARCL1,SPARC-like protein 1,14979,432,1.53 [1.13-2.06],0.0054819033803727
Chapter II Neoplasms,Leiomyoma of uterus,SPINK1,Serine protease inhibitor Kazal-type 1,14985,426,0.73 [0.59-0.90],0.0034758257242425
Chapter II Neoplasms,Leiomyoma of uterus,SPINK5,Serine protease inhibitor Kazal-type 5,14985,426,1.33 [1.03-1.72],0.0282467351943917
Chapter II Neoplasms,Leiomyoma of uterus,SPON1,Spondin-1,15020,420,1.77 [1.39-2.25],3.857232430731219e-06
Chapter II Neoplasms,Leiomyoma of uterus,SPON2,Spondin-2,14918,423,1.98 [1.55-2.52],3.841239472523626e-08
Chapter II Neoplasms,Leiomyoma of uterus,SRPX,Sushi repeat-containing protein SRPX,13013,361,1.68 [1.24-2.27],0.0008412793721534
Chapter II Neoplasms,Leiomyoma of uterus,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,15023,432,1.34 [1.10-1.63],0.0034322229752535
Chapter II Neoplasms,Leiomyoma of uterus,ST13,Hsc70-interacting protein,12715,355,0.83 [0.69-0.99],0.0377136512630529
Chapter II Neoplasms,Leiomyoma of uterus,STC2,Stanniocalcin-2,14964,425,2.43 [1.78-3.32],1.968378225332387e-08
Chapter II Neoplasms,Leiomyoma of uterus,TAFA5,Chemokine-like protein TAFA-5,14932,422,1.50 [1.18-1.90],0.0007455969595158
Chapter II Neoplasms,Leiomyoma of uterus,TCN2,Transcobalamin-2,15149,432,0.72 [0.54-0.97],0.0326212650835663
Chapter II Neoplasms,Leiomyoma of uterus,TCOF1,Treacle protein,13013,361,0.66 [0.46-0.93],0.0186005898187336
Chapter II Neoplasms,Leiomyoma of uterus,TEK,Angiopoietin-1 receptor,15038,426,0.56 [0.39-0.79],0.0009256192609177
Chapter II Neoplasms,Leiomyoma of uterus,TF,Serotransferrin,13027,358,2.21 [1.44-3.40],0.0003113974622758
Chapter II Neoplasms,Leiomyoma of uterus,TFRC,Transferrin receptor protein 1,15033,432,1.74 [1.46-2.06],3.0874236940034557e-10
Chapter II Neoplasms,Leiomyoma of uterus,THBD,Thrombomodulin,14989,424,0.54 [0.39-0.75],0.0002495608963047
Chapter II Neoplasms,Leiomyoma of uterus,THBS2,Thrombospondin-2,14985,426,1.72 [1.39-2.13],6.2445367300618e-07
Chapter II Neoplasms,Leiomyoma of uterus,THBS4,Thrombospondin-4,14978,430,1.61 [1.34-1.93],3.515703222055088e-07
Chapter II Neoplasms,Leiomyoma of uterus,THOP1,Thimet oligopeptidase,14932,421,0.58 [0.43-0.77],0.0002026371887559
Chapter II Neoplasms,Leiomyoma of uterus,THPO,Thrombopoietin,14726,419,0.74 [0.59-0.94],0.0118061383783712
Chapter II Neoplasms,Leiomyoma of uterus,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,15023,432,0.81 [0.67-0.99],0.0363332727802021
Chapter II Neoplasms,Leiomyoma of uterus,TIMP2,Metalloproteinase inhibitor 2,13013,361,1.68 [1.31-2.16],4.1580322590980585e-05
Chapter II Neoplasms,Leiomyoma of uterus,TIMP4,Metalloproteinase inhibitor 4,14985,426,0.71 [0.57-0.89],0.0025717061385466
Chapter II Neoplasms,Leiomyoma of uterus,TINAGL1,Tubulointerstitial nephritis antigen-like,14940,423,0.67 [0.46-0.98],0.041132744530226
Chapter II Neoplasms,Leiomyoma of uterus,TMPRSS11D,Transmembrane protease serine 11D,12935,357,0.72 [0.54-0.96],0.0240330225405527
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,14888,417,0.56 [0.41-0.77],0.0004292367368564
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,14993,419,0.63 [0.47-0.84],0.0017740178121971
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,14692,416,0.80 [0.64-0.98],0.0338874868895958
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,12715,355,0.67 [0.52-0.87],0.0026498270658592
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,15124,428,0.72 [0.52-0.99],0.04347761988742
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,15128,428,0.70 [0.55-0.90],0.0052267362773101
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,14888,417,0.83 [0.70-0.98],0.0310169253807788
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,15124,428,0.69 [0.56-0.84],0.000298677501239
Chapter II Neoplasms,Leiomyoma of uterus,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,14888,417,0.66 [0.52-0.84],0.0008794993011964
Chapter II Neoplasms,Leiomyoma of uterus,TNFSF13,Tumor necrosis factor ligand superfamily member 13,15068,428,1.46 [1.06-2.00],0.019386598853558
Chapter II Neoplasms,Leiomyoma of uterus,TNNI3,"Troponin I, cardiac muscle",14726,419,1.13 [1.01-1.26],0.0302204597268937
Chapter II Neoplasms,Leiomyoma of uterus,TPK1,Thiamin pyrophosphokinase 1,13013,361,0.62 [0.44-0.86],0.003861243681842
Chapter II Neoplasms,Leiomyoma of uterus,TPSG1,Tryptase gamma,12645,344,0.64 [0.42-0.97],0.0373322520399395
Chapter II Neoplasms,Leiomyoma of uterus,TREM2,Triggering receptor expressed on myeloid cells 2,14993,419,0.81 [0.68-0.95],0.0118367082835771
Chapter II Neoplasms,Leiomyoma of uterus,TSNAX,Translin-associated protein X,12603,340,0.68 [0.52-0.89],0.004769983561226
Chapter II Neoplasms,Leiomyoma of uterus,TSPAN1,Tetraspanin-1,14726,419,1.77 [1.56-2.02],1.0217697683396353e-18
Chapter II Neoplasms,Leiomyoma of uterus,TST,Thiosulfate sulfurtransferase,14593,411,0.89 [0.79-1.00],0.0481035854526675
Chapter II Neoplasms,Leiomyoma of uterus,TTR,Transthyretin,12881,350,0.67 [0.46-0.99],0.0426399948621418
Chapter II Neoplasms,Leiomyoma of uterus,TXN,Thioredoxin,12787,355,0.74 [0.58-0.95],0.0189638879232802
Chapter II Neoplasms,Leiomyoma of uterus,VEGFD,Vascular endothelial growth factor D,15131,426,1.32 [1.03-1.69],0.0292890095642024
Chapter II Neoplasms,Leiomyoma of uterus,VMO1,Vitelline membrane outer layer protein 1 homolog,14932,422,0.88 [0.78-1.00],0.0464304177988734
Chapter II Neoplasms,Leiomyoma of uterus,VSNL1,Visinin-like protein 1,12968,358,0.71 [0.53-0.95],0.0199830118669434
Chapter II Neoplasms,Leiomyoma of uterus,VTCN1,V-set domain-containing T-cell activation inhibitor 1,14633,414,1.69 [1.38-2.06],4.321792893279749e-07
Chapter II Neoplasms,Leiomyoma of uterus,VWC2,Brorin,14834,416,1.93 [1.54-2.41],7.465771597579195e-09
Chapter II Neoplasms,Leiomyoma of uterus,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",14847,415,1.53 [1.24-1.87],5.0976538651286696e-05
Chapter II Neoplasms,Leiomyoma of uterus,YOD1,Ubiquitin thioesterase OTU1,12603,340,0.83 [0.71-0.98],0.029659357473777
Chapter II Neoplasms,Leiomyoma of uterus,ZBP1,Z-DNA-binding protein 1,12645,344,0.72 [0.53-0.97],0.0304970370129903
